Literature DB >> 24990390

Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease.

Malleshappa Pavan1.   

Abstract

BACKGROUND: One of the main goals in chronic kidney disease (CKD) patients is to diminish the accumulation of uremic toxins and to slow the progression of renal failure. We investigated whether prebiotic and probiotic supplementation along with low protein diet retards the progression of CKD.
METHODS: This is a 12-month prospective observation study with a randomized control and open-label design. A total of 24 stable CKD stage III to V patients, who are not on renal replacement therapy, were enrolled in this study. Patients were randomly assigned to 2 groups: low protein diet + prebiotic + probiotic supplementation (N.=12), receiving 3 tablets of prebiotic + probiotic supplementation daily for 6 months, and the control group receiving low protein diet only (N.=12). We examined the effects of prebiotic and probiotic supplementation on estimated glomerular filtration rate (eGFR) in CKD.
RESULTS: The declining GFR during prebiotic and probiotic supplementation were significantly lower (-11.6±8.6 vs. -3.4±4.6 mL/min per 1.73 m2 per year, 95% CI -6.45 - -9.86, P<0.001) than those with low protein diet alone.
CONCLUSIONS: Prebiotic and probiotic supplementation along with low protein diet delayed the progression of CKD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990390

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  20 in total

Review 1.  Probiotics and chronic kidney disease.

Authors:  Laetitia Koppe; Denise Mafra; Denis Fouque
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

Review 2.  Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

Authors:  Dorothy A Kieffer; Roy J Martin; Sean H Adams
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

3.  Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Charat Thongprayoon; Wisit Kaewput; Spencer T Hatch; Tarun Bathini; Konika Sharma; Karn Wijarnpreecha; Patompong Ungprasert; Matthew D'Costa; Michael A Mao; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2018-08-11       Impact factor: 3.199

Review 4.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

5.  Effects of probiotic VSL#3 on glomerular filtration rate in dogs affected by chronic kidney disease: A pilot study.

Authors:  Ilaria Lippi; Francesca Perondi; Gianila Ceccherini; Veronica Marchetti; Grazia Guidi
Journal:  Can Vet J       Date:  2017-12       Impact factor: 1.008

Review 6.  The gut microbiota and its relationship with chronic kidney disease.

Authors:  Consuelo Plata; Cristino Cruz; Luz G Cervantes; Victoria Ramírez
Journal:  Int Urol Nephrol       Date:  2019-10-01       Impact factor: 2.370

Review 7.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

Review 8.  Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.

Authors:  Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2020-02-17       Impact factor: 3.657

Review 9.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

10.  An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Ighli di Bari; Paola Maria Acquaviva; Valentina Maranzano; Simone Corciulo; Agostino Di Ciaula; Domenica Maria Di Palo; Flavia Maria La Forgia; Sergio Fontana; Maria De Angelis; Piero Portincasa; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2021-05-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.